Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-FR | Version v9-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-02-09 | 2023-02-09 |
| Drug Identification Number | 02139510 | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | SODIUM CHLORIDE INJECTION, USP | SODIUM CHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | SODIUM CHLORIDE | SODIUM CHLORIDE |
| Strength(s) | 234MG | 234MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 30mL | 30mL |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2022-10-03 | 2022-10-03 |
| Actual start date | 2022-10-03 | 2022-10-03 |
| Estimated end date | 2023-02-01 | 2023-02-01 |
| Actual end date | 2023-01-31 | 2023-01-31 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Product is on 100% allocation. We will be encountering a supply interruption on our Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL effective December 1, 2022 until February 1, 2023. Effective December 1, 2022, allocations for our Sodium Chloride Injection, USP 4 mEq/mL Maxivial® 100 mL will be increased. Contract customers will be allocated 100% of historical 100 mL demand plus 100% of historical 30 mL demand on a 1:2 ratio (1 vial of 100 mL = 2 vials of 30 mL). | Product is on 100% allocation. We will be encountering a supply interruption on our Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL effective December 1, 2022 until February 1, 2023. Effective December 1, 2022, allocations for our Sodium Chloride Injection, USP 4 mEq/mL Maxivial® 100 mL will be increased. Contract customers will be allocated 100% of historical 100 mL demand plus 100% of historical 30 mL demand on a 1:2 ratio (1 vial of 100 mL = 2 vials of 30 mL). |
| Health Canada comments |